Physician profile
Joaquin Cabrera
NPI 1063517381
$773.37
in general payments reported to CMS, 2019-2025
20 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $444 · 2020: $215 · 2021: $114.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $129.69 | 2019-2021 | |
| Takeda Pharmaceuticals U.S.A., INC. | $93.07 | 2020-2021 | |
| Mallinckrodt Enterprises LLC | $71.23 | 2019 | |
| Bayer Healthcare Pharmaceuticals INC. | $65.40 | 2019-2020 | |
| Shire North American Group INC | $52.38 | 2019 | |
| Philips North America LLC | $49.43 | 2019 | |
| Mallinckrodt Hospital Products INC. | $47.80 | 2020 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $43.91 | 2019-2021 | |
| Abbvie INC. | $33.33 | 2019-2021 | |
| Organon LLC | $21.02 | 2021 | |
| Mylan Specialty L.P. | $20.03 | 2020 | |
| Circassia INC. | $19.43 | 2019 | |
| Regeneron Healthcare Solutions, INC. | $18.62 | 2019 | |
| Genentech USA, INC. | $18.42 | 2019 | |
| Roche Diagnostics Corporation | $17.42 | 2019 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Actelion Pharmaceuticals US, INC. | $16.69 | 2019 | |
| Amag Pharmaceuticals, INC. | $16.03 | 2019 | |
| Lupin INC. | $14.56 | 2019 | |
| Myovant Sciences INC. | $13.27 | 2021 | |
| Allergan, INC. | $11.64 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Joaquin Cabrera listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.